Does carboplatin cause neuropathy?
Peripheral neuropathy is uncommon when conventional doses of carboplatin are used, but patients over 65 years of age may be at higher risk. Carboplatin may be associated with peripheral neuropathy in about 4% to 15% of patients.
If carboplatin is combined with other neurotoxic cancer treatments, or used at higher doses or for prolonged periods, the risk of more severe neuropathy may increase.
Peripheral neuropathy due to cancer treatments (chemotherapy) can cause symptoms of pain, weakness, and numbness from nerve damage, usually in the hands and feet. Symptoms of neuropathy may persist, or even worsen, for months after drug treatment is stopped.
Carboplatin is a platinum-based chemotherapy agent, but neuropathy symptoms with carboplatin treatment tend to be mild in most cases. Anticancer drugs that are commonly associated with more severe neuropathy include the platinum agents cisplatin and oxaliplatin.
What do studies say?
In clinical studies when a carboplatin regimen was compared to a cisplatin regimen in 393 patients for the treatment of ovarian cancer, peripheral neuropathy occurred in 16% of patients receiving the carboplatin regimen compared to 42% in the cisplatin regimen arm, a significant difference.
Patients older than 65 years of age or previously treated with cisplatin may be at a greater risk of neuropathies, in up to 10% of patients. However, in 70% of patients pretreated with cisplatin who had already developed peripheral neurotoxicity, their symptoms did not worsen with carboplatin therapy.
Other neurologic complications of carboplatin therapy may include retinal (eye) toxicity that may lead to vision loss and ototoxicity that may lead to hearing loss or ringing in the ears (tinnitus), although these side effects tend to be more common with cisplatin.
This is not all the possible side effects that may occur with carboplatin. Talk with your doctor about any possible side effects before treatment with this medicine.
Related questions
- Why give Taxol (Paxel) before carboplatin?
- What is TCHP chemotherapy and how is it used?
- How does carboplatin stop cancer?
Learn More:
Carboplatin: Side Effects, Warnings and What to Avoid
This is not all the information you need to know about carboplatin for safe and effective use and does not take the place of talking to your doctor about your treatment. Review the full carboplatin information here, and discuss this information and any questions you have with your doctor or other health care provider.
References
- Addington J, Freimer M. Chemotherapy-induced peripheral neuropathy: an update on the current understanding. F1000Res. 2016;5:F1000 Faculty Rev-1466. Published 2016 Jun 22. doi:10.12688/f1000research.8053.1
- Lee EQ, et al. Overview of neurologic complications of platinum-based chemotherapy. Up to Date. Sept. 14, 2021. Accessed October 5, 2021 at https://www.uptodate.com/contents/overview-of-neurologic-complications-of-platinum-based-chemotherapy
- DailyMed. US National Library of Medicine. NIH. Carboplatin prescribing information. Fresenius Kabi. Lake Zurich, Ill. Updated Dec. 31, 2019. Accessed Oct. 5, 2021 at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b4fa7aac-c9d2-4af4-a281-3e6cfc502ff6&audience=consumer
Read next
What is the strongest chemotherapy drug for breast cancer?
Doxorubicin is considered one of the strongest chemotherapy drugs for breast cancer ever invented. It can kill cancer cells at every point in their life cycle, and it's used to treat a wide variety of cancers, not just breast cancer. Doxorubicin is also known as “The Red Devil” because it is a clear bright red color. It can cause your urine or other body fluids to turn a reddish color for 1 to 2 days after a dose is given, which is normal and temporary. Continue reading
Is small cell or non-small cell lung cancer worse?
Generally, small cell lung cancer (SCLC) is worse than non-small cell lung cancer (NSCLC). SCLC accounts for about 10-15% of people who have lung cancer and is the most aggressive form of lung cancer. SCLC usually starts in the breathing tubes (bronchi), and although the cells are small, they grow very quickly and create large tumors. Early on in the course of the disease, there are rarely any symptoms. If caught early (limited-stage disease) 20-25% of people can be potentially cured. Extensive SCLC is more difficult to treat. Continue reading
Is non-small cell lung cancer hereditary?
A hereditary family history of lung cancer is one of the many risk factors for developing non-small cell lung cancer. About 8% of lung cancers are thought to be inherited or linked to gene changes, but smoking and air pollution remain the primary causes of lung cancer. Continue reading
Related medical questions
- How aggressive is non-small cell lung cancer?
- Does smoking cause non-small cell lung cancer?
- What type of prostate cancer is Erleada used to treat?
- What type of lung cancer is Vizimpro used to treat?
- What type of cancer is Tecentriq used to treat?
- What type of cancer is Daurismo (glasdegib) used to treat?
- Oxycodone vs Hydrocodone - How do they compare?
- Does omeprazole cause cancer?
- Why is Xanax so addictive?
- Does Ozempic cause cancer?
- How do you increase platelet count during chemotherapy?
- What is the TC chemo regimen and how does it treat breast cancer?
- What are monoclonal antibodies?
- Vicodin vs Percocet: What's the difference?
- What is Quercetin and what are its health benefits?
- How do I know if immunotherapy is working?
- What are anti-VEGF drugs (VEGF inhibitors)?
- My stool has changed color. What does it mean?
- Treatments for Menopause
- How do I know if Aldara is working for skin cancer?
- How does Ibrance kill cancer?
- Does Skyrizi cause cancer?
- Does Xolair cause cancer?
- Is food coloring bad for you?
- What is a chemotherapy regimen?
- How do Herceptin (trastuzumab) and Perjeta (pertuzumab) work together?
Drug information
- Carboplatin Information for Consumers
- Carboplatin prescribing info & package insert (for Health Professionals)
- Side Effects of Carboplatin (detailed)
- Carboplatin user reviews (5)
Related support groups
- Carboplatin (4 questions, 14 members)
- Cancer (187 questions, 644 members)
- Peripheral Neuropathy (104 questions, 835 members)
- Ovarian Cancer (12 questions, 56 members)
- Cervical Cancer (6 questions, 25 members)